Tuesday, February 2, 2016

Drug Makers Calculated Price Increases With Profit in Mind, Memos Show by ANDREW POLLACK and MATTHEW GOLDSTEIN


By ANDREW POLLACK and MATTHEW GOLDSTEIN

Documents released by a congressional panel show that Valeant Pharmaceuticals and Turing Pharmaceuticals set revenue goals from old drugs, and raised prices accordingly, as much as fiftyfold.

Published: February 3, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1nE3pEC



from WordPress http://ift.tt/1mb1E0q
via Hadi Aboukhater
at

No comments:

Post a Comment